Log In
BCIQ
Print this Print this
 

Nplate, Romiplate, romiplostim

Also known as: formerly AMG 531

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionRecombinant fusion protein containing a pair of thrombopoietin (TPO) receptor-binding domains
Molecular Target Thrombopoietin (TPO) receptor (CD110) (Mpl)
Mechanism of ActionThrombopoietin (TPO) receptor (CD110) (Mpl) agonist
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$20.9M

$20.9M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/11/2011

$20.9M

$20.9M

0

Get a free BioCentury trial today